Free Trial

Arteris, Inc. (NASDAQ:AIP) Director Sells $297,508.08 in Stock

Arteris logo with Computer and Technology background

Key Points

  • Arteris, Inc. Director Saiyed Atiq Raza sold 29,544 shares at an average price of $10.07, totaling approximately $297,508, reducing his ownership by 4.33%.
  • The company's stock is currently trading at $9.86, with a market cap of $413.92 million and a price-to-earnings ratio of -12.02.
  • Hedge funds and institutional investors own 64.36% of Arteris, with several increasing their stakes significantly in the first quarter of the year.
  • Need better tools to track Arteris? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 29,544 shares of Arteris stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $10.07, for a total transaction of $297,508.08. Following the sale, the director owned 653,118 shares of the company's stock, valued at approximately $6,576,898.26. The trade was a 4.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Saiyed Atiq Raza also recently made the following trade(s):

  • On Friday, July 18th, Saiyed Atiq Raza sold 1,136 shares of Arteris stock. The stock was sold at an average price of $10.00, for a total transaction of $11,360.00.
  • On Friday, June 27th, Saiyed Atiq Raza sold 19,809 shares of Arteris stock. The stock was sold at an average price of $10.02, for a total transaction of $198,486.18.

Arteris Stock Up 0.8%

Shares of AIP traded up $0.07 during mid-day trading on Monday, reaching $9.12. 83,936 shares of the company's stock were exchanged, compared to its average volume of 324,292. The company has a 50-day simple moving average of $8.89 and a two-hundred day simple moving average of $8.40. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $12.64. The company has a market cap of $382.90 million, a price-to-earnings ratio of -11.13 and a beta of 1.45.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reissued a "buy" rating and set a $14.00 price objective on shares of Arteris in a research note on Wednesday, May 21st.

Get Our Latest Stock Analysis on AIP

Institutional Trading of Arteris

Several hedge funds and other institutional investors have recently bought and sold shares of AIP. G2 Investment Partners Management LLC purchased a new stake in Arteris in the 4th quarter worth approximately $2,799,000. Acadian Asset Management LLC grew its stake in Arteris by 40.6% in the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock worth $6,222,000 after acquiring an additional 260,277 shares during the period. AQR Capital Management LLC purchased a new stake in Arteris in the 1st quarter worth approximately $1,621,000. Federated Hermes Inc. grew its stake in Arteris by 97.2% in the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after acquiring an additional 161,241 shares during the period. Finally, Next Century Growth Investors LLC grew its stake in Arteris by 46.4% in the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock worth $2,817,000 after acquiring an additional 129,143 shares during the period. 64.36% of the stock is owned by hedge funds and other institutional investors.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Further Reading

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines